FDA

Requiring Formal Rulemaking Is a Thinly Veiled Attempt to Halt Regulation

Regulatory reform bill’s public hearing requirement will hinder agencies’ attempts to regulate.

Looking More Closely at the Platypus of Formal Rulemaking

Legal scholar argues that the oft-criticized formal rulemaking process has virtues in proper settings.

Encourage Vaping to Help Reduce Smoking

Scholar argues that governments should embrace vaping’s smoking-cessation potential.

FDA Takes Action to Curb Overuse of Antimicrobials in Livestock

Amid growing concerns about “superbugs,” regulators seek comment on use of antimicrobials in animal feed.

Time to Get Graphic with Cigarette Labels?

FDA is years behind in its statutory mandate to put graphic warnings on cigarette labels.

The Uncertain Benefits of GMO Labeling

Scholar argues that regulators will have difficulty applying cost-benefit analysis to mandatory GMO labeling.

A More Holistic Definition of “Healthy”

Regulator solicits input on a new rule defining when foods could be considered “healthy.”

Still Seeking Contraceptive Compromise After Zubik v. Burwell

Zubik v. Burwell highlights thorny issues surrounding Obamacare’s contraceptive coverage requirement.

Challenges in Measuring Regulatory Capture

Regulatory capture, neither inevitable nor a death trap for agencies, must be reduced to advance public policy goals.

We Need to Get Back to Work

Reviving our regulatory system should be a top priority for the next President.

Creating Guidance for an Invisible Threat

FDA issues new guidelines to medical device manufacturers to mitigate cybersecurity concerns.

Regulatory Agenda Offers Glimpse Into Obama Adminstration Priorities

Agenda details some of the Administration’s high priority rules for 2016.